Mexico Selective Serotonin Reuptake Inhibitors Market Size & Outlook
Related Markets
Mexico selective serotonin reuptake inhibitors market highlights
- The Mexico selective serotonin reuptake inhibitors market generated a revenue of USD 1,202.9 million in 2025 and is expected to reach USD 1,639.1 million by 2033.
- The Mexico market is expected to grow at a CAGR of 4% from 2026 to 2033.
- In terms of segment, sertraline was the largest revenue generating drug type in 2025.
- Sertraline is the most lucrative drug type segment registering the fastest growth during the forecast period.
Selective serotonin reuptake inhibitors market data book summary
| Market revenue in 2025 | USD 1,202.9 million |
| Market revenue in 2033 | USD 1,639.1 million |
| Growth rate | 4% (CAGR from 2026 to 2033) |
| Largest segment | Sertraline |
| Fastest growing segment | Sertraline |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sertraline, Fluoxetine, Escitalopram, Paroxetine |
Other key industry trends
- In terms of revenue, Mexico accounted for 6.2% of the global selective serotonin reuptake inhibitors market in 2025.
- Country-wise, Canada is expected to lead the global market in terms of revenue in 2033.
- In North America, Canada selective serotonin reuptake inhibitors market is projected to lead the regional market in terms of revenue in 2033.
- Canada is the fastest growing regional market in North America and is projected to reach USD 7,037.8 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Selective Serotonin Reuptake Inhibitors Market Scope
Selective Serotonin Reuptake Inhibitors Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| H. Lundbeck AS Class A | View profile | 5700 | Ottiliavej 9, Valby, Denmark, 2500 | https://www.lundbeck.com |
| GlaxoSmithKline Consumer Healthcare (GSK CH India) | View profile | 1001-5000 | Gurgaon, Haryana, India, Asia | https://india-consumer.gsk.com/ |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Mexico selective serotonin reuptake inhibitors market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to selective serotonin reuptake inhibitors market will help companies and investors design strategic landscapes.
Sertraline was the largest segment with a revenue share of 29.5% in 2025. Horizon Databook has segmented the Mexico selective serotonin reuptake inhibitors market based on sertraline, fluoxetine, escitalopram, paroxetine covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Mexico selective serotonin reuptake inhibitors market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico selective serotonin reuptake inhibitors market databook
-
Our clientele includes a mix of selective serotonin reuptake inhibitors market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico selective serotonin reuptake inhibitors market , including forecasts for subscribers. This country databook contains high-level insights into Mexico selective serotonin reuptake inhibitors market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico selective serotonin reuptake inhibitors market size, by drug type, 2021-2033 (US$M)
Mexico Selective Serotonin Reuptake Inhibitors Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
